Explore 3 Stock Ideas & Industry Insights Download Free Report

News

TORM CFO Kim Balle Sells 42,533 Shares Over Three Days

TORM plc Chief Financial Officer Kim Balle filed a Form 4 with the SEC on September 24, 2026, disclosing the sale of 42,533 Class A Common Shares across three transactions between September 18 and September 22, 2026.

Anjali Anand | 24 September 2026

111, Inc. Director Chen Yang Luke Reports RSU Sales

A Form 4 filed on September 24, 2026 discloses changes in beneficial ownership of Class A ordinary share RSUs by Chen Yang Luke, a director of 111, Inc. (NASDAQ:YI), covering transactions dated as early as September 8, 2023 through September 23, 2026.

Aditi Sarkar | 24 September 2026

IDT Corporation Declares $0.07 Quarterly Cash Dividend

IDT Corporation filed a Form 8-K with the SEC on September 23, 2026, disclosing that its Board of Directors declared a quarterly cash dividend of $0.07 per share, payable on October 14, 2026.

Shwetambri Chauhan | 24 September 2026

News Corporation Discloses ASX Share Repurchase Activity

News Corporation filed a Form 8-K on September 24, 2026, reporting that it provided share repurchase transaction disclosures to the Australian Securities Exchange, with the date of earliest event reported as September 23, 2026.

Manish Choudhary | 24 September 2026

AMC Entertainment Prices $2 Billion Notes and $850 Million Term Loans

AMC Entertainment Holdings, Inc. filed a Form 8-K on September 24, 2026, reporting that on September 23, 2026, it priced $2,000 million in 8.875% first lien notes due 2031 and $850 million in first lien term loans as part of a broader debt refinancing …

Anjali Anand | 24 September 2026

First Merchants Corporation Prices $100M Subordinated Notes Offering

First Merchants Corporation filed a current report on Form 8-K dated September 23, 2026, disclosing its entry into an underwriting agreement and the pricing of a $100,000,000 subordinated notes offering.

Aditi Sarkar | 24 September 2026

Lantern Pharma Discloses Open-Medicine AI Webinar

Lantern Pharma Inc. filed a Form 8-K with the SEC on September 24, 2026, disclosing that the company hosted a live webinar on September 23, 2026, to discuss its Open-Medicine AI multi-agentic AI platform for drug development.

Aditi Sarkar | 24 September 2026

Jaguar Health Exchanges Shares to Reduce Promissory Note Balance

Jaguar Health, Inc. filed a Form 8-K on September 24, 2026, disclosing that on September 23, 2026, the company entered into exchange agreements with Streeterville Capital, LLC to issue 547,898 shares of common stock in exchange for a reduction in the outstanding balance of …

Manish Choudhary | 24 September 2026

Kyverna Therapeutics Reports Positive KYSA-8 and KYSA-6 Trial Data

Kyverna Therapeutics, Inc. filed a Form 8-K on September 24, 2026, disclosing positive one-year data from its registrational trial KYSA-8 and positive longer-term follow-up data from the Phase 2 portion of its registrational trial KYSA-6, both evaluating miv-cel (mivocabtagene autoleucel, KYV-101).

Shwetambri Chauhan | 24 September 2026

TruGolf Holdings Separates from Christopher Jones, Appoints New Director

TruGolf Holdings, Inc. filed a Form 8-K with the SEC on September 24, 2026, reporting the September 22, 2026 resignation of Christopher Jones from all roles, the execution of a Separation and Settlement Agreement, and the appointment of Jay Heller to the Company's Board …

Manish Choudhary | 24 September 2026
Support

Hi! How can we help you today?

Loading…